It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Japan medical bodies aim to develop tailored drugs to treat rare diseases

National / Science & Health Dec 25, 2022

Japan medical bodies aim to develop tailored drugs to treat rare diseases

Japanese researchers plan to develop tailored drugs and treatments for patients with extremely rare diseases.

Japan approves blood test to detect Alzheimer’s

National / Science & Health Dec 22, 2022

Japan approves blood test to detect Alzheimer’s

Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon. Sysmex’s diagnostic product that measures amyloid beta in the ...

Injectable HIV treatment offers hope to Ugandan patients

World / Science & Health Dec 22, 2022

Injectable HIV treatment offers hope to Ugandan patients

Some hope the new treatment option could help to reduce the stigma HIV patients suffer, particularly gay men.

Takeda to pay up to $6 billion for Nimbus immune-therapy drug

Business / Corporate Dec 14, 2022

Takeda to pay up to $6 billion for Nimbus immune-therapy drug

by John Lauerman

After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.

Johnson & Johnson's Japan unit searched over alleged antitrust violation

Business Dec 13, 2022

Johnson & Johnson's Japan unit searched over alleged antitrust violation

The Japan Fair Trade Commission suspects Johnson & Johnson K.K. and ASP Japan of obstructing competitors' sales of cleaners and disinfectants for endoscopes.

Shionogi says Japan government to buy 1 million more COVID pill doses

National / Science & Health Dec 13, 2022

Shionogi says Japan government to buy 1 million more COVID pill doses

The added supply agreement comes at a time when Japan is dealing with an eighth wave of COVID-19 infections.

Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge

Business Nov 30, 2022

Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge

by Robert Langreth

The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.

Eisai and Biogen plunge after report of second death in Alzheimer’s trial

Business / Financial Markets Nov 29, 2022

Eisai and Biogen plunge after report of second death in Alzheimer’s trial

by Naomi Kresge

The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.

Researchers test mRNA technology for universal flu vaccine

World / Science & Health Nov 25, 2022

Researchers test mRNA technology for universal flu vaccine

by Nancy Lapid

A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.

Shionogi applies for COVID-19 vaccine approval, would be first Japan-made

National / Science & Health Nov 24, 2022

Shionogi applies for COVID-19 vaccine approval, would be first Japan-made

The recombinant protein-based preventive vaccine is the same type as a COVID-19 vaccine developed by Novavax and differs from messenger RNA vaccines developed by Pfizer or Moderna.

Japan's Daiichi Sankyo says mRNA COVID vaccine successful in booster trial

National / Science & Health Nov 15, 2022

Japan's Daiichi Sankyo says mRNA COVID vaccine successful in booster trial

Approval would give Japan a home-grown source for mRNA vaccines, which have made up the bulk of its COVID-19 inoculations to date.

Lotte made its name in candy. Now it’s moving into drugmaking.

Business / Corporate Oct 26, 2022

Lotte made its name in candy. Now it’s moving into drugmaking.

The new direction comes after a number of prominent South Korean family-run businesses turned to the highly profitable $1.3 trillion global biopharma business.

« 1 … 5 6 7 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times